Skip to main content
. 2004 Jan 20;90(2):449–454. doi: 10.1038/sj.bjc.6601536

Table 4. Growth factor receptors in 21 patients with a PSA-positive PRTR biopsy changing to PSA negativity at the development of AIPC.

  PRTR biopsy AIPC biopsy Pa
IHC positivity      
 c-erbB-1 6 (29%) 11 (52%) 0.180
 c-erbB-2 8 (38%) 3 (14%) 0.125
 c-erbB-3 5 (24%) 5 (24%) 1.00
 c-erbB-4 7 (33%) 7 (33%) 1.00
a

McNemar test for related samples.

HHS Vulnerability Disclosure